Selected research
Industry Research
Exosome Isolation Service Industry Research Report 2026
Market perspective
The global Exosome Isolation Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Exosome Isolation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Exosome Isolation Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Exosome Isolation Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Exosome Isolation Service include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Creative Biostructure, AMSBIO, Everzom, System Biosciences and Creative Biolabs, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Exosome Isolation Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Exosome Isolation Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exosome Isolation Service Market by Company
Codiak Biosciences
Aethlon Medical
NanoSomix
Aruna Bio
Creative Biostructure
AMSBIO
Everzom
System Biosciences
Creative Biolabs
Frontage Labs
Lonza
Capital Biosciences
Miltenyi Biotec
Novus Biologicals
Clara Biotech
Immunostep
ExosomeDx
Irvine Scientific
Beckman Coulter
Stratech
QIAGEN
Lifeasible
Exosome Isolation Service Segment by Type
Ultracentrifugation
Immunomagnetic Bead Method
Size Exclusion Chromatography
Exosome Isolation Service Segment by Application
Early Cancer Screening
Neurological Disease Diagnosis
Drug Delivery System Development
Regenerative Medicine
Other
Exosome Isolation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Isolation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Isolation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Isolation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Exosome Isolation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ultracentrifugation
- Immunomagnetic Bead Method
- Size Exclusion Chromatography
Applications
- Early Cancer Screening
- Neurological Disease Diagnosis
- Drug Delivery System Development
- Regenerative Medicine
- Other
Companies covered
- Codiak Biosciences
- Aethlon Medical
- NanoSomix
- Aruna Bio
- Creative Biostructure
- AMSBIO
- Everzom
- System Biosciences
- Creative Biolabs
- Frontage Labs
- Lonza
- Capital Biosciences
- Miltenyi Biotec
- Novus Biologicals
- Clara Biotech
- Immunostep
- ExosomeDx
- Irvine Scientific
- Beckman Coulter
- Stratech
- QIAGEN
- Lifeasible
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exosome Isolation Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ultracentrifugation
- 2.2.3 Immunomagnetic Bead Method
- 2.2.4 Size Exclusion Chromatography
- 2.3 Exosome Isolation Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Early Cancer Screening
- 2.3.3 Neurological Disease Diagnosis
- 2.3.4 Drug Delivery System Development
- 2.3.5 Regenerative Medicine
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Exosome Isolation Service Breakdown Data by Type
- 3.1 Global Exosome Isolation Service Historic Market Size by Type (2021-2026)
- 3.2 Global Exosome Isolation Service Forecasted Market Size by Type (2027-2032)
4 Exosome Isolation Service Breakdown Data by Application
- 4.1 Global Exosome Isolation Service Historic Market Size by Application (2021-2026)
- 4.2 Global Exosome Isolation Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Exosome Isolation Service Market Perspective (2021-2032)
- 5.2 Global Exosome Isolation Service Growth Trends by Region
- 5.2.1 Global Exosome Isolation Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Exosome Isolation Service Historic Market Size by Region (2021-2026)
- 5.2.3 Exosome Isolation Service Forecasted Market Size by Region (2027-2032)
- 5.3 Exosome Isolation Service Market Dynamics
- 5.3.1 Exosome Isolation Service Industry Trends
- 5.3.2 Exosome Isolation Service Market Drivers
- 5.3.3 Exosome Isolation Service Market Challenges
- 5.3.4 Exosome Isolation Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Exosome Isolation Service Players by Revenue
- 6.1.1 Global Top Exosome Isolation Service Players by Revenue (2021-2026)
- 6.1.2 Global Exosome Isolation Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Exosome Isolation Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Exosome Isolation Service Head Office and Area Served
- 6.4 Global Exosome Isolation Service Players, Product Type & Application
- 6.5 Global Exosome Isolation Service Manufacturers Established Date
- 6.6 Global Exosome Isolation Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Exosome Isolation Service Market Size (2021-2032)
- 7.2 North America Exosome Isolation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Exosome Isolation Service Market Size by Country (2021-2026)
- 7.4 North America Exosome Isolation Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Exosome Isolation Service Market Size (2021-2032)
- 8.2 Europe Exosome Isolation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Exosome Isolation Service Market Size by Country (2021-2026)
- 8.4 Europe Exosome Isolation Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Isolation Service Market Size (2021-2032)
- 9.2 Asia-Pacific Exosome Isolation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Exosome Isolation Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Exosome Isolation Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Exosome Isolation Service Market Size (2021-2032)
- 10.2 South America Exosome Isolation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Exosome Isolation Service Market Size by Country (2021-2026)
- 10.4 South America Exosome Isolation Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Isolation Service Market Size (2021-2032)
- 11.2 Middle East & Africa Exosome Isolation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Exosome Isolation Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Exosome Isolation Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Codiak Biosciences
- 12.1.1 Codiak Biosciences Company Information
- 12.1.2 Codiak Biosciences Business Overview
- 12.1.3 Codiak Biosciences Revenue in Exosome Isolation Service Business (2021-2026)
- 12.1.4 Codiak Biosciences Exosome Isolation Service Product Portfolio
- 12.1.5 Codiak Biosciences Recent Developments
- 12.2 Aethlon Medical
- 12.2.1 Aethlon Medical Company Information
- 12.2.2 Aethlon Medical Business Overview
- 12.2.3 Aethlon Medical Revenue in Exosome Isolation Service Business (2021-2026)
- 12.2.4 Aethlon Medical Exosome Isolation Service Product Portfolio
- 12.2.5 Aethlon Medical Recent Developments
- 12.3 NanoSomix
- 12.3.1 NanoSomix Company Information
- 12.3.2 NanoSomix Business Overview
- 12.3.3 NanoSomix Revenue in Exosome Isolation Service Business (2021-2026)
- 12.3.4 NanoSomix Exosome Isolation Service Product Portfolio
- 12.3.5 NanoSomix Recent Developments
- 12.4 Aruna Bio
- 12.4.1 Aruna Bio Company Information
- 12.4.2 Aruna Bio Business Overview
- 12.4.3 Aruna Bio Revenue in Exosome Isolation Service Business (2021-2026)
- 12.4.4 Aruna Bio Exosome Isolation Service Product Portfolio
- 12.4.5 Aruna Bio Recent Developments
- 12.5 Creative Biostructure
- 12.5.1 Creative Biostructure Company Information
- 12.5.2 Creative Biostructure Business Overview
- 12.5.3 Creative Biostructure Revenue in Exosome Isolation Service Business (2021-2026)
- 12.5.4 Creative Biostructure Exosome Isolation Service Product Portfolio
- 12.5.5 Creative Biostructure Recent Developments
- 12.6 AMSBIO
- 12.6.1 AMSBIO Company Information
- 12.6.2 AMSBIO Business Overview
- 12.6.3 AMSBIO Revenue in Exosome Isolation Service Business (2021-2026)
- 12.6.4 AMSBIO Exosome Isolation Service Product Portfolio
- 12.6.5 AMSBIO Recent Developments
- 12.7 Everzom
- 12.7.1 Everzom Company Information
- 12.7.2 Everzom Business Overview
- 12.7.3 Everzom Revenue in Exosome Isolation Service Business (2021-2026)
- 12.7.4 Everzom Exosome Isolation Service Product Portfolio
- 12.7.5 Everzom Recent Developments
- 12.8 System Biosciences
- 12.8.1 System Biosciences Company Information
- 12.8.2 System Biosciences Business Overview
- 12.8.3 System Biosciences Revenue in Exosome Isolation Service Business (2021-2026)
- 12.8.4 System Biosciences Exosome Isolation Service Product Portfolio
- 12.8.5 System Biosciences Recent Developments
- 12.9 Creative Biolabs
- 12.9.1 Creative Biolabs Company Information
- 12.9.2 Creative Biolabs Business Overview
- 12.9.3 Creative Biolabs Revenue in Exosome Isolation Service Business (2021-2026)
- 12.9.4 Creative Biolabs Exosome Isolation Service Product Portfolio
- 12.9.5 Creative Biolabs Recent Developments
- 12.10 Frontage Labs
- 12.10.1 Frontage Labs Company Information
- 12.10.2 Frontage Labs Business Overview
- 12.10.3 Frontage Labs Revenue in Exosome Isolation Service Business (2021-2026)
- 12.10.4 Frontage Labs Exosome Isolation Service Product Portfolio
- 12.10.5 Frontage Labs Recent Developments
- 12.11 Lonza
- 12.11.1 Lonza Company Information
- 12.11.2 Lonza Business Overview
- 12.11.3 Lonza Revenue in Exosome Isolation Service Business (2021-2026)
- 12.11.4 Lonza Exosome Isolation Service Product Portfolio
- 12.11.5 Lonza Recent Developments
- 12.12 Capital Biosciences
- 12.12.1 Capital Biosciences Company Information
- 12.12.2 Capital Biosciences Business Overview
- 12.12.3 Capital Biosciences Revenue in Exosome Isolation Service Business (2021-2026)
- 12.12.4 Capital Biosciences Exosome Isolation Service Product Portfolio
- 12.12.5 Capital Biosciences Recent Developments
- 12.13 Miltenyi Biotec
- 12.13.1 Miltenyi Biotec Company Information
- 12.13.2 Miltenyi Biotec Business Overview
- 12.13.3 Miltenyi Biotec Revenue in Exosome Isolation Service Business (2021-2026)
- 12.13.4 Miltenyi Biotec Exosome Isolation Service Product Portfolio
- 12.13.5 Miltenyi Biotec Recent Developments
- 12.14 Novus Biologicals
- 12.14.1 Novus Biologicals Company Information
- 12.14.2 Novus Biologicals Business Overview
- 12.14.3 Novus Biologicals Revenue in Exosome Isolation Service Business (2021-2026)
- 12.14.4 Novus Biologicals Exosome Isolation Service Product Portfolio
- 12.14.5 Novus Biologicals Recent Developments
- 12.15 Clara Biotech
- 12.15.1 Clara Biotech Company Information
- 12.15.2 Clara Biotech Business Overview
- 12.15.3 Clara Biotech Revenue in Exosome Isolation Service Business (2021-2026)
- 12.15.4 Clara Biotech Exosome Isolation Service Product Portfolio
- 12.15.5 Clara Biotech Recent Developments
- 12.16 Immunostep
- 12.16.1 Immunostep Company Information
- 12.16.2 Immunostep Business Overview
- 12.16.3 Immunostep Revenue in Exosome Isolation Service Business (2021-2026)
- 12.16.4 Immunostep Exosome Isolation Service Product Portfolio
- 12.16.5 Immunostep Recent Developments
- 12.17 ExosomeDx
- 12.17.1 ExosomeDx Company Information
- 12.17.2 ExosomeDx Business Overview
- 12.17.3 ExosomeDx Revenue in Exosome Isolation Service Business (2021-2026)
- 12.17.4 ExosomeDx Exosome Isolation Service Product Portfolio
- 12.17.5 ExosomeDx Recent Developments
- 12.18 Irvine Scientific
- 12.18.1 Irvine Scientific Company Information
- 12.18.2 Irvine Scientific Business Overview
- 12.18.3 Irvine Scientific Revenue in Exosome Isolation Service Business (2021-2026)
- 12.18.4 Irvine Scientific Exosome Isolation Service Product Portfolio
- 12.18.5 Irvine Scientific Recent Developments
- 12.19 Beckman Coulter
- 12.19.1 Beckman Coulter Company Information
- 12.19.2 Beckman Coulter Business Overview
- 12.19.3 Beckman Coulter Revenue in Exosome Isolation Service Business (2021-2026)
- 12.19.4 Beckman Coulter Exosome Isolation Service Product Portfolio
- 12.19.5 Beckman Coulter Recent Developments
- 12.20 Stratech
- 12.20.1 Stratech Company Information
- 12.20.2 Stratech Business Overview
- 12.20.3 Stratech Revenue in Exosome Isolation Service Business (2021-2026)
- 12.20.4 Stratech Exosome Isolation Service Product Portfolio
- 12.20.5 Stratech Recent Developments
- 12.21 QIAGEN
- 12.21.1 QIAGEN Company Information
- 12.21.2 QIAGEN Business Overview
- 12.21.3 QIAGEN Revenue in Exosome Isolation Service Business (2021-2026)
- 12.21.4 QIAGEN Exosome Isolation Service Product Portfolio
- 12.21.5 QIAGEN Recent Developments
- 12.22 Lifeasible
- 12.22.1 Lifeasible Company Information
- 12.22.2 Lifeasible Business Overview
- 12.22.3 Lifeasible Revenue in Exosome Isolation Service Business (2021-2026)
- 12.22.4 Lifeasible Exosome Isolation Service Product Portfolio
- 12.22.5 Lifeasible Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst